Centro de Investigación Médica Aguascalientes - CIMA

En el Centro de Investigación Médica Aguascalientes, impulsamos a nuestro equipo a descubrir y desarrollar sus talentos, favoreciendo su participación con proyectos desafiantes e innovadores que contribuyan a los avances de la investigación Clínica en México.
logoCentro de Investigación Médica Aguascalientes - CIMA
Av Independencia 2130, Trojes de Alonso, Aguascalientes
Select an option

Specializations

Diabetes

Open studies

Migraine
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine - PIONEER-PEDS1 - Eli Lilly and CompanySee more
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine - REBUILD-1 - Eli Lilly and CompanySee more
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine - REBUILD-2 - Eli Lilly and CompanySee more
Skin cancer
A Study to Evaluate Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Resected Melanoma - AmgenSee more
A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma - AmgenSee more
Diabetes
Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure - Laboratorios Silanes S.A. de C.V.See more
Gastrointestinal stromal tumors
(Peak) a Phase 3 Randomized Trial of CGT9486+Sunitinib Vs. Sunitinib in Subjects with Gastrointestinal Stromal Tumors - Cogent Biosciences, Inc.See more
Myeloproliferative syndromes
Study of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis - Kartos Therapeutics, Inc.See more
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy